Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, an

Tags:: Diabetes Clinical Study Liraglutide Blood Sugar Pressure Ada Glucose Oad Glimepiride Multivu 33424

Please wait while the video loads.
You will need Adobe's Flash Player plugin to view this page propertly.

Edit Video Details Editing Options

Submitter:
MultiVu
Visits: 44,976
Subscribers: 46
Comments: 0
Updated: 15-Oct-08
Videos: 1065

International
Comments: 0
Views: 159
Added: 10-Jun-08

Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes Data presented today at the 68th Scientific Sessions of the American Diabetes Association (ADA) demonstrated that once-daily liraglutide when taken alone produced statistically significant improvement in blood sugar (glucose) control in patients with type 2 diabetes, as compared to glimepiride, a widely used oral anti-diabetic drug (OAD). In addition, liraglutide demonstrated the following benefits compared to glimepiride: -Statistically significant reduction in body weight -Statistically significant reduction in risk of hypoglycemia -Statistically significant reduction in systolic blood pressure In this 12-month study, 62% of patients treated with liraglutide who had not been previously treated with diabetes medications achieved an average reduction in blood sugar that brought them below the ADA target for HbA1c of 7%. To view Multimedia News release go to, http://www.prnewswire.com/mnr/novonordisk/33424/ More»

Categories: News & Events

Comments on